Skip to content

Author

Pouya Mahdavi Sharif

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Immune checkpoint inhibitor-induced diabetes mellitus: A review of mechanisms, clinical features, and therapeutic approaches.

Since the FDA approval of ipilimumab in 2011, immune checkpoint inhibitors (ICIs) have reshaped the paradigm of cancer treatments. This has been pursued with the development and clinical investigation of combination immunotherapies with multiple ICIs. However, more than 20% of recipients of ICI monotherapy and a higher...

Mohammad Parsapour, Pouya Mahdavi Sharif, Nima Rezaei · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.